The overexpression of NRP1 in tumor tissue has been correlated with worse prognosis in gastric cancer [39,40], cervical cancer [42], ovarian carcinoma [43], breast cancer [44], non-small cell lung cancer (NSCLC) [45], osteosarcoma [47], bladder cancer [46], glioma [49], nasopharyngeal carcinoma [48], and pancreatic ductal adenocarcinoma [41], among others. The gene discussed is NRP1; the disease is pancreatic ductal adenocarcinoma.